Abstract

Lantibiotics are potential alternatives to antibiotics because of their broad-range killing spectrum. The producer strain is immune against its own synthesized lantibiotic via the expression of two proteins LanI and LanFEG. Recently, gene operons are found in mainly human pathogenic strains, which confer resistance against lantibiotics. Of all the lantibiotics discovered till date, nisin produced by some Lactococcus lactis strains is the most prominent member. Nisin has multiple mode of actions of which binding to the cell wall precursor lipid II and subsequent insertion into the bacterial membrane to form pores are the most effective. The nisin producing strains express the lipoprotein NisI to prevent a suicidal effect. NisI binds nisin, inducing a reversible cell clustering to prevent nisin from reaching the membrane. Importantly NisI does not modify nisin and releases it as soon as the concentration in the media drops below a certain level. The human pathogen Streptococcus agalactiae is naturally resistant against nisin by expressing a resistance protein called SaNSR, which is a nisin degrading enzyme. By cleaving off the last six amino acids of nisin, its effectiveness is 100-fold reduced. This cleavage reaction appears to be specific for nisin since SaNSR recognizes the C-terminal located lanthionine rings. Recently, the structures of both NisI and SaNSR were determined by NMR and X-ray crystallography, respectively. Furthermore, for both proteins the binding site for nisin was determined. Within this review, the structures of both proteins and their different defense mechanisms are described.

Highlights

  • Since the beginning of the last century, the heterogeneous group of bacteriocins have become an interesting research topic for various applications like food preservatives or pharmaceutical purposes as antibiotic alternatives (Cleveland et al, 2001; Cotter et al, 2012)

  • The nisin producing L. lactis strains are immune against the high antimicrobial activity of nisin via the expression of an distinct immunity system consisting of the lipoprotein NisI and ABC transporter NisFEG (Figure 1)

  • In Streptococcus agalactiae, the operon identified confers resistance against the lantibiotic nisin and resembles the genetic architecture of the nisI and nisFEG immunity genes found in the producing L. lactis strain (Khosa et al, 2013; Figure 1)

Read more

Summary

Introduction

Since the beginning of the last century, the heterogeneous group of bacteriocins have become an interesting research topic for various applications like food preservatives or pharmaceutical purposes as antibiotic alternatives (Cleveland et al, 2001; Cotter et al, 2012). The nisin producing L. lactis strains are immune against the high antimicrobial activity of nisin via the expression of an distinct immunity system consisting of the lipoprotein NisI and ABC transporter NisFEG (Figure 1). In Streptococcus agalactiae, the operon identified confers resistance against the lantibiotic nisin and resembles the genetic architecture of the nisI and nisFEG immunity genes found in the producing L. lactis strain (Khosa et al, 2013; Figure 1).

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call